27.83 0.00 (0.00%)
After hours: 4:02PM EST
|Bid||27.86 x 800|
|Ask||27.86 x 800|
|Day's Range||27.46 - 28.18|
|52 Week Range||22.05 - 31.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Dec 09, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||32.83|
Phreesia is best known in the health care industry for its automated patient intake software, available on mobile devices or tablets. The company went public this morning and shares are soaring and Yahoo Finance's Adam Shapiro and Julie Hyman spoke to Phreesia CEO Chaim Indig about the debut.
From health care legislation to mergers and acquisitions, 2019 was busy for the health care market. Industry experts say the excitement is just beginning.
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking. Hedge funds underperform because their net exposure in only 40-70% and they charge exorbitant fees. No one knows what the future holds and how market participants will react to the bountiful news that floods in each […]
Phreesia, Inc. ("Phreesia") (NYSE: PHR), a leading patient intake management platform, announced today the closing of the underwritten secondary public offering of a total of 7,762,500 shares of its common stock (the "Shares") by certain of Phreesia’s existing stockholders (the "Selling Stockholders"), which includes the full exercise of the underwriters’ option to purchase 1,012,500 additional Shares from the Selling Stockholders. The Shares were sold at a public offering price of $26.00 per share and were purchased by the underwriters from the Selling Stockholders at the public offering price less the underwriting discount. The Company did not receive any proceeds from the sale of the Shares.
Phreesia, Inc. ("Phreesia") (NYSE:PHR), a leading patient intake management platform, announced today the pricing of the previously announced underwritten secondary offering of a total of 6,750,000 shares of its common stock at a price to the public of $26.00 per share, all of which will be sold by certain of Phreesia’s existing stockholders (the "Selling Stockholders"). In addition, the Selling Stockholders have granted the underwriters an option for 30 days to purchase up to 1,012,500 additional shares of common stock to cover overallotments, if any, at the public offering price, less the underwriting discount (the "Secondary Offering").
Last week saw the newest third-quarter earnings release from Phreesia, Inc. (NYSE:PHR), an important milestone in the...
Phreesia, Inc. ("Phreesia") (NYSE: PHR), a leading patient intake management platform, announced today the launch of an underwritten secondary public offering of a total of 6,000,000 shares of its common stock (the "Secondary Offering"), to be offered by certain of Phreesia’s existing stockholders (the "Selling Stockholders"). In addition, the Selling Stockholders expect to grant to the underwriters an option for 30 days to purchase up to 900,000 additional shares of common stock to cover overallotments, if any, at the public offering price, less the underwriting discount. Phreesia will not receive any proceeds from the Secondary Offering but will bear costs associated with the sale of such shares.
Phreesia, Inc. (NYSE: PHR) ("Phreesia") announced financial results today for the fiscal third quarter and nine months ended October 31, 2019.
Phreesia, Inc. will hold a conference call on Tuesday, December 10, 2019, at 8:30 a.m. Eastern Time to review the Company's fiscal third quarter 2020 financial results.
Lafayette General Health, a non-profit regional health system serving south central Louisiana, and Phreesia, the nation’s leading patient intake platform, are excited to announce they have partnered to offer Lafayette General Health’s patients a more modern, convenient and engaging experience. Lafayette General Health went live with Phreesia's automated patient intake platform in five of its clinics. After three weeks of success, the organization rolled out Phreesia across nearly all of the Lafayette General Medical Doctors (LGMD) sites.
Phreesia, the nation’s leading patient intake platform, is excited to announce that Kharen Hauck, the company’s Vice President of Demand Generation, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2019. The annual list recognizes 50 women across the country for their leadership and accomplishments in the Software-as-a-Service industry and the broader technology field. Honorees were selected based on integrity, drive and promoting a positive work environment, among other areas.
NEW YORK, NY / ACCESSWIRE / September 10, 2019 / Phreesia Inc (NYSE: PHR ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on September 10, 2019 at 8:30 AM Eastern ...
NEW YORK , Aug. 19, 2019 /PRNewswire/ -- Phreesia, Inc. (NYSE: PHR) ("Phreesia") will hold a conference call on Tuesday, September 10, 2019 , at 8:30 a.m. Eastern Time to review the Company's ...
NEW YORK , July 22, 2019 /PRNewswire/ -- Phreesia, Inc. (NYSE: PHR) ("Phreesia"), a leading patient intake management platform, today announced the closing of its initial public offering of 10,681,423 ...
Phreesia — the health care software company that’s using technology to make both providers and patients lives easier — made its public debut today on the New York Stock Exchange.
(Bloomberg) -- The popping phenomenon in technology IPOs extended into the second half on Thursday, when health care software developer Phreesia Inc. surged as much as 53% above its offering price.Phreesia’s pop follows ten other initial public offerings that debuted at least 50% above their IPO prices in June. It’s the first U.S. technology firm to go public since the calendar’s annual pause for Independence Day vacations, providing proof that the mania for new issues is still going strong more than a month after traders piled into arrivals like like Chewy Inc. and CrowdStrike Holdings Inc.Phreesia’s IPO priced above its offering range on Wednesday. The next U.S. technology firm planning to go public is Medallia Inc., whose IPO is expected to also price above-range on Thursday.To contact the reporter on this story: Drew Singer in New York at email@example.comTo contact the editors responsible for this story: Brad Olesen at firstname.lastname@example.org, Steven FrommFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
NEW YORK , July 17, 2019 /PRNewswire/ -- Phreesia, Inc. ("Phreesia"), a leading patient intake management platform, today announced the pricing of its initial public offering of 9,288,194 shares ...
For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. Douyu International Holdings Ltd (DOYU) will issue nearly 67.4 million ...